Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial.

MLA

O’Mahony, Denis, et al. “Prevention of Adverse Drug Reactions in Hospitalized Older Patients with Multi-Morbidity and Polypharmacy: The SENATOR* Randomized Controlled Clinical Trial.” Age & Ageing, vol. 49, no. 4, July 2020, pp. 605–14. EBSCOhost, https://doi.org/10.1093/ageing/afaa072.

APA

O’Mahony, D., Gudmundsson, A., Soiza, R. L., Petrovic, M., Cruz-Jentoft, A. J., Cherubini, A., Fordham, R., Byrne, S., Dahly, D., Gallagher, P., Lavan, A., Curtin, D., Dalton, K., Cullinan, S., Flanagan, E., Shiely, F., Samuelsson, O., Sverrisdottir, A., Subbarayan, S., & Vandaele, L. (2020). Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial. Age & Ageing, 49(4), 605–614. https://doi.org/10.1093/ageing/afaa072

Chicago

O’Mahony, Denis, Adalsteinn Gudmundsson, Roy L Soiza, Mirko Petrovic, Alfonso Jose Cruz-Jentoft, Antonio Cherubini, Richard Fordham, et al. 2020. “Prevention of Adverse Drug Reactions in Hospitalized Older Patients with Multi-Morbidity and Polypharmacy: The SENATOR* Randomized Controlled Clinical Trial.” Age & Ageing 49 (4): 605–14. doi:10.1093/ageing/afaa072.